| abstract |
The invention relates to application of tricyclic chinoline and quinoxaline derivatives as well as a pharmaceutical composition containing the tricyclic chinoline and quinoxaline derivatives as a modifier, in particular agonists or partial agonists of a 5-HT2C receptor, application of the tricyclic chinoline and quinoxaline derivatives to preparing drugs for preventing or treating regulation response conditions and diseases of the 5-HT2c receptor, a method used for preventing or treating the regulation response conditions and diseases of the 5-HT2c receptor, and a method for preparing the compounds and the composition. |